Vice Chair Rozo’s Prepared Testimony before the Senate Committee on Finance, Subcommittee on Health Care
Vice Chair Rozo’s Prepared Testimony before the Senate Committee on Finance, Subcommittee on Health Care On August 4, 2026, Dr. Michele Rozo testified before the U.S. Senate Committee on Finance, Subcommittee on Health Care for a hearing titled: “Building a Resilient Health Care Future with Biotechnology.” Download
The BIO-SCALE Act of 2026
The Bioindustrial Infrastructure for Open Scale-up, Commercialization, and Accelerated Launch Ecosystems (BIO-SCALE Act) This legislation would direct the Secretary of Commerce to establish at least three nonprofit, product-agnostic precommercial scale-up facilities to enable and accelerate the scaling of non-pharmaceutical biotechnologies. Download
Colorado Biotech Unlocking Critical Minerals for U.S. National Security
Colorado Biotech Unlocking Critical Minerals for U.S. National Security As China leverages critical mineral supply chains for geopolitical gain, the United States must embrace the power of innovative biomining to reach vast untapped resources of domestic critical minerals. 27, July 2026 FOR IMMEDIATE RELEASE Denver, Colorado – Last week, the National Security Commission on Emerging […]
Accelerating Rare Disease Innovation through an All-of-Government Strategy
Accelerating Rare Disease Innovation through an All-of-Government Strategy The U.S. biotechnology ecosystem could lead the world in developing cures for rare disease, but without a unified national strategy to fund, develop, and regulate new therapies, that lead is eroding. Retaining America’s edge in rare disease therapeutics is a national security and health security imperative. 21 […]
NSCEB Monthly Newsletter – July 2026
NSCEB Monthly Newsletter July 2026 Across the Hill, bipartisan, bicameral momentum for action to secure American biotechnology is accelerating. The House and Senate Armed Services Committees both included multiple biotech provisions in their respective versions of the FY27 National Defense Authorization Act (NDAA), and a bipartisan group of Members introduced the Web of Biological Data Act in both chambers. See below for details on […]
Biological Data, Biodiversity, and Innovation Cornerstones of San Diego Biotech Ecosystem
Biological Data, Biodiversity, and Innovation Cornerstones of San Diego Biotech Ecosystem World-class biobanking programs and high-tech innovations are generating a wealth of biological data and driving scientific discovery in wildlife conservation. 26, June 2026 FOR IMMEDIATE RELEASE San Diego, California – This week, the National Security Commission on Emerging Biotechnology (NSCEB) visited San Diego and Escondido, California to explore a strong biotech ecosystem that is leveraging advanced technology […]
Senate Committee Again Advances Biotech Priorities for Defense
Senate Committee Again Advances Biotech Priorities for Defense The Senate Armed Service Committee’s release of the FY27 NDAA cements biotechnology as a defense priority and builds on the strategic biotechnology provisions in last year’s NDAA. 19 June 2026 FOR IMMEDIATE RELEASE Washington, DC – The The Senate Armed Services Committee (SASC) released its markup of the FY27 National Defense Authorization Act (NDAA) and included a number of significant provisions focused on elevating and […]
Web of Biological Data Act of 2026
Web of Biological Data Act of 2026 This legislation would direct the Secretary of Energy to establish the Web of Biological Data (WOBD), a single point of entry for researchers to access high-quality biological data, especially those managed or funded by the federal government. Download
Congress Takes Steps to Make Biological Data a Strategic National Resource
Congress Takes Steps to Make Biological Data a Strategic National Resource As AI converges with biotechnology, the U.S. government must lead in the curation, management, and protection of biological data necessary to ensure America continues to lead the world in AIxBio 11 June 2026 FOR IMMEDIATE RELEASE Washington, DC – Today, a bipartisan and bicameral group of Members of Congress introduced legislation to provide streamlined access to high-quality biological data for U.S. researchers in the era of AIxBio. The Web of Biological […]
U.S. vs. China: Government Action on Key NSCEB Recommendations
New NSCEB Analysis: Chinese Government Leveraging U.S. Biotechnology Playbook 11 June 2026 FOR IMMEDIATE RELEASE Washington, DC – New analysis from the National Security Commission on Emerging Biotechnology (NSCEB) shows how the Chinese Communist Party (CCP) is advancing its own biotechnology sector using strategies outlined in the NSCEB’s April 2025 Action Plan for U.S. biotechnology. This underscores the urgency for U.S. policymakers to implement NSCEB recommendations to strengthen our own biotech industry. The […]
